• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA RUNTHROUGH NS; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA RUNTHROUGH NS; WIRE, GUIDE, CATHETER Back to Search Results
Model Number 25-1013
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 10/25/2024
Type of Reportable Event Serious Injury
Event or Problem Description
The user facility reported that a 7x150mm smart vascular stent (c07150ml lot 18328912) was deployed over a terumo runthrough 0.014" wire (manufacturer code 25-1013, lot 240201y) in the left distal superficial femoral artery (sfa).During deployment, the distal end of the wire became trapped behind the stent.In attempting to remove the wire from the stent, there was damage to the distal edge of the smart stent.Multiple attempts were made to disengage the wire and remove it.Attempts were also made to re-cross and balloon the distal edge of the stent, which resulted in further damage to the stent.The patient was ultimately transferred to an acute care hospital for vascular surgery.The access sites were: right common femoral artery; left anterior tibial artery.Sheaths used: rfa: 6f 45cm terumo destination sheath left anterior tibial artery: 6f cordis rain sheath other wires used during the procedure: cordis aquatrack ((b)(6)) terumo glidewire advantage.035" terumo glidewire advantage.014".Lesion information: total occlusion of left superficial femoral artery from ostial to popliteal.Previously treated.Patient discontinued medications.Moderate calcification lesion treated with auryon laser atherectomy and percutaneous transluminal angioplasty (pta) prior to stent placement.Additional information was received on 14nov2024: the patient was stable when they left their obl and the patient was doing fine post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUNTHROUGH NS
Common Device Name
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key20794073
Report Number2243441-2024-00038
Device Sequence Number18090546
Product Code DQX
UDI-Device Identifier04987350703583
UDI-Public(01)04987350703583(17)270131(10)240201
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 11/27/2024
Report Date (Section F) 11/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number25-1013
Device Catalogue Number25-1013
Device Lot Number240201Y
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date10/30/2024
Device Age8 MO
Event Location Hospital
Date Report to Manufacturer10/31/2024
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date11/27/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
6FR 45CM TERUMO DESTINATION SHEATH; 6FR CORDIS RAIN SHEATH; 7 X 150MM SMART VASCULAR STENT; CORDIS AQUATRACK ((B)(6)); TERUMO GLIDEWIRE ADVANTAGE .014"; TERUMO GLIDEWIRE ADVANTAGE .035"
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient Age80 YR
Patient SexMale
Patient Weight83 KG
Date Report Sent to FDA11/27/2024
-
-